ACCC institute launches to diversify cancer clinical trials

By The Science Advisory Board staff writers

June 4, 2021 -- The Association of Community Cancer Centers (ACCC) announced the launch of the ACCC Community Oncology Research Institute (ACORI), which aims to close the gap in cancer research through more diverse community oncology partnerships.

The institute is working to establish clinical trials as a standard of care in treatment plans and to help achieve equitable cancer care delivery for all patients, focusing on equity, capacity building, and research diffusion.

Through partnerships that support ACORI's mission, the ACCC is collaborating with the American Society of Clinical Oncology (ASCO) to increase participation in cancer clinical trials among patients from underrepresented racial and ethnic groups. The two organizations are currently recruiting 40 oncology research programs to be part of a pilot that tests a site assessment tool and an implicit bias training program.

The organizations are also seeking a mix of small and large oncology programs from diverse regions around the country, and participating programs will receive a stipend.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter